Showing results (1291-1300 of 5,035) with videos related to
Sort By:
Pageof 504
Clinical Laboratory|August 3, 2004
Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantationKlaus Janitschke, Thomas Held, Dominique Krüiger, et al.Clinical Laboratory|August 3, 2004
Decision limit for troponin I on ADVIA:Centaur and evaluation of the analytical precision at low concentrationsAntonio Fortunato, Davide GiavarinaClinical Laboratory|August 3, 2004
Oxidative stress in hemodialysis--postdialytic changesK V Dakshinamurty, P V L N Srinivasa Rao, K S S Saibaba, et al.Clinical Laboratory|April 13, 2004
Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patientsMarie-France Pichon, Kamel Hacene, Sylvie Guepratte, et al.Clinical Laboratory|April 13, 2004
Comparability of method results and performance in a national external quality assessment scheme between 1993 and 2003 using thyroid associated antibodies as examplesWilliam Graham Wood, Reiner HankeClinical Laboratory|April 12, 2005
Thrombosis and bleeding: when opposites are not so far apartMassimo Franchini, Dino VeneriClinical Laboratory|April 12, 2005
Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE automated chemiluminescence assay system in different blood specimensMartin W Elmlinger, Manfred Zwirner, Werner KühnelClinical Laboratory|April 12, 2005
Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBANagina Parmar, Leslie R Berry, Nethnapha Paredes, et al.Clinical Laboratory|February 22, 2005
The latest from the ivd industry: prevention, diagnosis and therapy of osteoporosisClinical Laboratory|February 22, 2005
Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNPEvangelos GiannitsisPageof 504